Longitudinal MRI Evaluation of Intracranial Development and Vascular Characteristics of Breast Cancer Brain Metastases in a Mouse Model

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Zhou, Heling ^a   Chen, Min ^b   Zhao, Dawen ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VOLUME; BRAIN DEVELOPMENT; BRAIN METASTASIS; BREAST CANCER; CANCER STAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; IN VIVO STUDY; INTRACRANIAL TUMOR; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR GROWTH; VASCULAR TUMOR; ANIMAL; BLOOD VESSEL; BRAIN NEOPLASMS; BREAST TUMOR; DISEASE MODEL; LONGITUDINAL STUDY; METABOLISM; NUDE MOUSE; PATHOLOGY; SECONDARY; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE;

EID: 84876923405     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062238     Document Type: Article

References (35)

1. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A, (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94: 2698-2705.
2. Lin NU, Bellon JR, Winer EP, (2004) CNS metastases in breast cancer. J Clin Oncol 22: 3608-3617.
3. Eichler AF, Chung E, Kodack DP, Loeffler JS, Fukumura D, et al. (2011) The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol.
4. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer Statistics, 2010. CA Cancer J Clin 60: 277-300.
5. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342.
6. Carbonell WS, Ansorge O, Sibson N, Muschel R, (2009) The Vascular Basement Membrane as "Soil" in Brain Metastasis. PLoS ONE 4: e5857.
7. Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, et al. (2003) Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 97: 2972-2977.
8. Melisko M, Moore D, Sneed P, De Franco J, Rugo H, (2008) Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival. Journal of Neuro-Oncology 88: 359-365.
9. Subramanian A, Harris A, Piggott K, Shieff C, Bradford R, (2002) Metastasis to and from the central nervous system-the 'relatively protected site'. Lancet Oncol 3: 498-507.
10. Begley DJ, (2004) Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther 104: 29-45.
11. Doolittle ND, Abrey LE, Bleyer WA, Brem S, Davis TP, et al. (2005) New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting. Clin Cancer Res 11: 421-428.
12. Zhang RD, Price JE, Fujimaki T, Bucana CD, Fidler IJ, (1992) Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice. Am J Pathol 141: 1115-1124.
13. Lockman PR, Mittapalli RK, Taskar KS, Rudraraju V, Gril B, et al. (2010) Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin Cancer Res 16: 5664-5678.
14. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R, (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16: 1486-1495.
15. Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, et al. (2007) Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res 67: 4190-4198.
16. Francia G, Cruz-Munoz W, Man S, Xu P, Kerbel RS, (2011) Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer 11: 135-141.
17. Lorger M, Felding-Habermann B, (2010) Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am J Pathol 176: 2958-2971.
18. Percy DB, Ribot EJ, Chen Y, McFadden C, Simedrea C, et al. (2011) In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach. Invest Radiol 46: 718-725.
19. Song HT, Jordan EK, Lewis BK, Liu W, Ganjei J, et al. (2009) Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation. J Transl Med 7: 88.
20. Rosen BR, Belliveau JW, Aronen HJ, Kennedy D, Buchbinder BR, et al. (1991) Susceptibility contrast imaging of cerebral blood volume: Human experience. Magnetic Resonance in Medicine 22: 293-299.
21. Kosaka N, Uematsu H, Kimura H, Ishimori Y, Kurokawa T, et al. (2007) Assessment of the Vascularity of Uterine Leiomyomas Using Double-Echo Dynamic Perfusion-Weighted MRI With the First-Pass Pharmacokinetic Model: Correlation With Histopathology. Investigative Radiology 42: 629-635 610.1097/RLI.1090b1013e318059ae318069.
22. Villringer A, Rosen BR, Belliveau JW, Ackerman JL, Lauffer RB, et al. (1988) Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 6: 164-174.
23. Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, et al. (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211: 791-798.
24. Cha S, Johnson G, Wadghiri YZ, Jin O, Babb J, et al. (2003) Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 49: 848-855.
25. Johnson G, Wetzel SG, Cha S, Babb J, Tofts PS, (2004) Measuring blood volume and vascular transfer constant from dynamic, T2*-weighted contrast-enhanced MRI. Magnetic Resonance in Medicine 51: 961-968.
26. Peereboom DM (2005) Chemotherapy in brain metastases. Neurosurgery 57: S54-65; discusssion S51-54.
27. Steeg PS, Camphausen KA, Smith QR, (2011) Brain metastases as preventive and therapeutic targets. Nat Rev Cancer 11: 352-363.
28. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, et al. (2007) Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 121: 901-907.
29. Kim SG, (1995) Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med 34: 293-301.
30. Wong EC, Buxton RB, Frank LR, (1998) A theoretical and experimental comparison of continuous and pulsed arterial spin labeling techniques for quantitative perfusion imaging. Magn Reson Med 40: 348-355.
31. Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, et al. (2008) Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology 247: 170-178.
32. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, et al. (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191: 41-51.
33. Fidler IJ, Yano S, Zhang RD, Fujimaki T, Bucana CD, (2002) The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3: 53-57.
34. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, et al. (2010) Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 16: 116-122.
35. Kusters B, Leenders WP, Wesseling P, Smits D, Verrijp K, et al. (2002) Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis. Cancer Res 62: 341-345.